- Home
- NNOX vs KIO Comparison
NNOX vs KIO Comparison
Compare NNOX & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- KIO
- Stock Information
- Founded
- NNOX 2018
- KIO 2011
- Country
- NNOX Israel
- KIO United States
- Employees
- NNOX N/A
- KIO 2400
- Industry
- NNOX Medical Electronics
- KIO Investment Managers
- Sector
- NNOX Health Care
- KIO Finance
- Exchange
- NNOX Nasdaq
- KIO Nasdaq
- Market Cap
- NNOX 432.5M
- KIO 356.5M
- IPO Year
- NNOX 2020
- KIO N/A
- Fundamental
- Price
- NNOX $8.38
- KIO $13.11
- Analyst Decision
- NNOX Strong Buy
- KIO
- Analyst Count
- NNOX 2
- KIO 0
- Target Price
- NNOX $17.50
- KIO N/A
- AVG Volume (30 Days)
- NNOX 4.0M
- KIO 136.5K
- Earning Date
- NNOX 11-21-2024
- KIO 01-01-0001
- Dividend Yield
- NNOX N/A
- KIO 10.82%
- EPS Growth
- NNOX N/A
- KIO N/A
- EPS
- NNOX N/A
- KIO N/A
- Revenue
- NNOX $10,680,000.00
- KIO N/A
- Revenue This Year
- NNOX $22.38
- KIO N/A
- Revenue Next Year
- NNOX $153.96
- KIO N/A
- P/E Ratio
- NNOX N/A
- KIO N/A
- Revenue Growth
- NNOX 10.79
- KIO N/A
- 52 Week Low
- NNOX $5.26
- KIO $10.52
- 52 Week High
- NNOX $14.28
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- NNOX 55.14
- KIO 39.13
- Support Level
- NNOX $7.17
- KIO $13.02
- Resistance Level
- NNOX $9.09
- KIO $13.67
- Average True Range (ATR)
- NNOX 0.97
- KIO 0.15
- MACD
- NNOX -0.05
- KIO -0.03
- Stochastic Oscillator
- NNOX 34.58
- KIO 13.85
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.